Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 54, 1924s-1928s, April 1, 1994]
© 1994 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rigaud, O.
Right arrow Articles by Moustacchi, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rigaud, O.
Right arrow Articles by Moustacchi, E.

Radioadaptation to the Mutagenic Effect of Ionizing Radiation in Human Lymphoblasts: Molecular Analysis of HPRT Mutants1

O. Rigaud and E. Moustacchi

Institut Curie-Biologie, 26 rue d'Ulm, 75231 Paris cedex 05, France [O. R., E. M.], and Institute de Protection et de Sureté Nucléaire, Departement de Protection de la Sauté l'Homme et de la Dosimétrie/Section Autonome de Radiobiologie Appliquée à la Medicine-Commissiariat à l'Energie Atomique, Postal Box 6F, 92265 Fontenay-aux-Roses cedex, France [O. R.]

A 70% reduction of HPRT- mutant frequency in radioadapted human lymphoblastoid cells has been reported, as analyzed by the Southern blot method (O. Rigaud et al., Radiat. Res., 133: 94–101, 1993). The data reported here extend the previous molecular analysis to a collection of 118 mutants. Structural rearrangements of the HPRT gene were determined using the multiplex polymerase chain reaction assay. This allows us to define more precisely the deleted exons in mutants and to ensure the absence of small alterations in exons among mutants with no detectable change after Southern analysis. The phenotype of these latter mutants is likely to be due to point mutations. Overall results of both Southern and multiplex polymerase chain reaction analyses confirm that the proportion of deletion-type mutations is decreased in adapted cells (42%) compared to that in mutants treated with the high dose alone (77%). Mutants with no change at the HPRT gene level were further characterized with respect to their HPRT gene expression. The vast majority of adapted mutants (86%) were still expressing mRNA, whereas HPRT transcripts were detected in only 56% of the mutants induced by the high dose alone. From these data and those reported by others, possible mechanisms underlying the adaptive response are proposed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1994 by the American Association for Cancer Research.